Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2409580 | Vaccine | 2006 | 9 Pages |
Abstract
ObjectiveBetter characterize and monitor adverse events following Dryvax® vaccinia vaccination in civilian health care workers and other first responders.DesignTelephone interviews to ascertain adverse events experienced.ResultsEight hundred twenty-five vaccinees, including 44 in the comparison group, were interviewed. At 10 days, 71.4% reported blisters, 35.1% reported bumps at the vaccination site, 48.5% swelling, 47.3% scab, tiredness/lethargy/fatigue (43.6%), headache (34.2%), lymph node swelling/tenderness (28.5%), muscle pain (23.1%), chills (14.4%), joint pain 11.8%, and fever >100 °F (12.5%). The 12.5% reported missing work because of vaccine adverse events. Most adverse events were anticipated and of short duration.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Arnulfo A. Muralles, Paula Ray, Steven Black, Henry Shinefield, Christine G. Casey, Scott Campbell, Robert T. Chen,